SpringWorks Therapeutics Inc (SWTX) — Capital Reinvestment Ratio
SpringWorks Therapeutics Inc (SWTX) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow ($15.07 Million) in capital expenditures ($54.00K). Check how tangible is SpringWorks Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SpringWorks Therapeutics Inc Capital Reinvestment Ratio (2004–2010)
This chart tracks SpringWorks Therapeutics Inc's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see SWTX cash flow metrics.
Annual Capital Reinvestment Ratio for SpringWorks Therapeutics Inc (2004–2010)
Year-by-year Capital Reinvestment Ratio for SpringWorks Therapeutics Inc from 2004 to 2010. See SpringWorks Therapeutics Inc (SWTX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.34x | $5.61 Million | $1.89 Million | ▲ +2.1% |
| 2009 | 0.33x | $5.23 Million | $1.73 Million | ▲ +274.2% |
| 2008 | 0.09x | $7.10 Million | $626.00K | ▼ -29.3% |
| 2007 | 0.12x | $5.70 Million | $710.00K | ▼ -92.2% |
| 2006 | 1.59x | $748.00K | $1.19 Million | ▲ +733.4% |
| 2005 | 0.19x | $4.01 Million | $766.00K | ▲ +91.7% |
| 2004 | 0.10x | $3.83 Million | $382.00K | — |